InvestorsHub Logo
Followers 84
Posts 12550
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Tuesday, 06/30/2020 8:05:00 AM

Tuesday, June 30, 2020 8:05:00 AM

Post# of 8716
Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA For Injection for the Treatment of Forehead Lines and Crow’s Feet, Respectively

https://investors.revance.com/news-releases/news-release-details/revance-announces-positive-results-two-phase-2a-studies
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News